Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I second that FFS!
Kangaroo court, where EPADI/Marjac are being tried. Sorry Marjac, but no way you can convince me these justices are honorable.
Amarin mgmt…the silence is deafening. Pricks!
Lemm, so then who argues the case in Nevada…our feeble minded mgmt team with inadequate representation…or The shareholders peoples choice..MARJAC!
Disappointed with Judges focus on what gives epadi the right to bring rule 60 procedure than hikmas fraud on the district court! Procedural bullsht.
Geez Nuke, pay attn, Marjac case not up to bat yet!
Better Call Saul! Kick some as Marjac!
You are right…I didn’t contribute to the brief…only the go fund me based on the epadi request wording.
Still confused?
Hopefully the judges won’t say the same about the cropped table ??
Good morning - in case you are unaware - Marjac/EPADI-II was granted oral arguments before the Federal Circuit Court of Appeals yesterday. Marjac will be appearing in person before the court - along with North (also of iHub fame) on February 11, 2022. To support this effort - EPADI-II is raising funds to cover any associated costs and travel. Please go to the following link to donate:
Marjac, quite commendable regarding multiple prong strategy, as Amarin mgmt never considered a backup strategy starting with the 2013 adcom debacle much to my dismay…
Jas, my sentiment as well…noticed the employee or legal beagle is emphasizing “mistake” over “fraud”?
Lettruth…what’s a control group if no placebo group as you say…?
Marjac and all, would Amarin face a substantial legal battle with existing lawsuits if the courts found that your arguments regarding obvious vrs non obvious had merit based on the cropping of the Kura table? I mean, I never could understand why Amarin legal counsel did not pursue this rule 60 motion themselves, although I’ve heard recently the existing lawsuits have something to do with that.
Thanks for any insight…
Done…saw the FB post. Awesome effort by Marjac and North and those who contributed. Hope they can accomplish what counsel for Amarin couldn’t!
Lol…ffs, musta been a private response cause inquiring minds would like to know.
FFS. So for the record ....are U buying? He will let you know after the fact lol
Gme eps -3.31. Amrn eps -.05. Makes me crazy
More dilution coming? Now that ema on board, JT will need funds for Gia since bo seems to be like finding a cure for cancer....ugh.
Medicare supplemental cvs caremark
I sent info to Amarin today...will see what their response is
Cvs pharmacy generic swap...doc called in vascepa 30 day, pharmacy said script was ready for pickup. I asked what is it? We have generic vascepa ready for pickup. I said did doc ask for generic...pharmacist... doctor did not specify. What’s price difference? Brand $82.80. Generic $71.25. Pharmacist asked if I wanted to switch to brand...yes. Can’t believe Amarin losing scripts over small price difference!
The law...it’s sad to come to the realization that’s innovation in the USA is stymied by a illogical judicial
system, and encourages foreign generics to prevail....
Hd...reality is not necessarily welcomed on this board...but your summation is about as close as it gets.
Biotech...according to the date of the article your 6 years too lat do stop vascepa.
Except rose, there have been plenty of times a doc would have to explain the reason for a certain prescription...to the insurance provider. Never had a script rejected?
Yes, but rose doesn’t seem to think so...or his response is lost in translation. So I’m not sure what he is saying that there is no vascepa with cvd label/indication....
VASCEPA is proven to reduce the risk of a life-threatening CV event by an additional 25% for adults on maximally tolerated statins with TG ≥150 mg/dL and established CVD or diabetes and ≥2 CVD risk factors1
Rose, as of today you are correct, but aren’t we waiting for the fda approval with cvd indication?
Cardio, so let me get this right...physician has patient with trigs over 500, he writes script for a) vascepa, b) generic vascepa, c) generic lovaza.
But for patient with trigs under 500, physician writes script for a) vascepa with cvd label, b) generic vascepa, c) generic lovaza, d) vascepa marine ?
Don’t most physicians write scripts for brand drugs first? Isn’t the problem really with the insurance carrier?
Scripts....at this rate, dilution Is on the horizon knowing this mgmt team.
Exactly...mumbo jumbo
I know whats coming by end of summer....yes Its called fall. Howsyour dow 19000 prediction?
Generic versions of vascepa by Amarin...which would be the only generic version with the CVD label...so wonder what the revenue projection would be?
My experience is that md’s will wrote script for brand name first. Rit label is foe cvd. So would expect md to indicate that so insurer covers. If switched to generic by insurer of pharmacy all you need is a patient o complain to amrn....i would be one of those patients. Now u got paper trail
So how did the opiate manufacturers manage to get sued?
R-it generic version...I would expect Amarin to go after any generic manufacturer who collects revenues for sales of their generic v that were filled for r-it indication.
Seems mr market recognizes fear...and buying oppty...ka-Ching $ !
Bearish....agreed, thankyou for the fear, another buying oppty.
HDg....”An invention composed entirely of pieces of prior art was nonetheless nonobvious, based largely on the fact that the patented invention fulfilled a long-felt need, achieved commercial success, and was the subject of skepticism on the part of experts, which the court called “strong evidence of nonobviousness. (Envtl. Designs, Ltd. v. Union Oil Co. of Cal., 713 F.2d 693, 697–98 (Fed. Cir. 1983)) ”
Awesome find, excellent work :)